Skip to main content

Investor Relations

Breaking Through the Blood-Brain Barrier

Cognos' Mission for Improved Healthcare

Cognos Therapeutics innovates healthcare with SINNAIS, an implantable smart pump uniting a programmable pump, intraventricular catheter, and wireless communication. Targeting CNS diseases like LC cancer, pancreatic cancer, and glioblastoma, SINNAIS surpasses the blood-brain barrier. The estimated U.S. market size is significant at $15.8 billion annually, emphasizing LC, pancreatic cancer, and glioblastoma treatments.

Investor Presentation

Latest Investor Presentation

2024 Investor Presentation

Download investor presentation

Press Releases

Sign up for Email Alerts

Stay connected and get the latest company news delivered to your inbox.

Stock Information


Cognos Therapeutics, Inc.




Day Range

52-week Range

Our Leadership Team

Cognos Therapeutics Inc.'s Board of Directors, composed of prominent figures from business, medical research, and scientific technology, plays a vital role as custodians of the company's financial interests. They actively set policies to advance the company's objectives, fulfilling their fiduciary duty to investors.

Meet our leadership team


Corporate Headquarters

Cognos Therapeutics, Inc.
10604 S La Cienega Blvd.
Inglewood, CA 90304

Investor Relations

Gilmartin Group
San Francisco
60 E Sir Francis Drake Blvd, Suite 208
Larkspur, CA 94939

Transfer Agent

Continental Stock Transfer and Trust
1 State Street, 30th Floor
New York, NY 10004-1561